Antacids Market: Current Analysis and Forecast (2022-2028)

$3999$6999

Emphasis on Drug Class (Proton pump inhibitors, H2 antagonist, Acid neutralizers, Others); Formulation (Tablets, Capsules, Suspension, Drops, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Region/Country

Pages:

212

Table:

42

Figure:

114

Report ID:

UMHE211073

Geography:

Clear
  Get a Sample
SKU: UMHE211073 Categories: , Tag:
Report Description
Table of content
Research Methodology

Report Description

Antacids Market
Antacids Market

The global antacids market is experiencing significant growth due to the increasing aging population and Gastroesophageal Reflux Disease (GERD), such as erosive esophagitis, Barrett esophagus, and esophageal cancer amongst the population, and awareness regarding gastrointestinal health among consumers. For Instance, In March 2020, Lupin launched the authorized generic for Horizon Therapeutics PLC’s Vimovo (naproxen/esomeprazole magnesium) delayed-release tablets in the United States. The product is a combination of naproxen, and esomeprazole magnesium, in which naproxen is used for symptomatic relief of arthritis and esomeprazole magnesium to decrease the risk of developing naproxen-associated gastric ulcers. Furthermore, PLC’s Vimovo is used when quick relief of your symptoms is required. Therefore, the market for antacids is expected to witness a significant CAGR of 9% during the forecast period.

Global Antacids Market is expected to register a CAGR of around 9% over the period of 2022-2028. This is mainly due to the growing geriatric population suffering from Gastroesophageal Reflux Disease (GERD), which occurs due to higher incidences of acidity, that results in the side effects of drugs like non-steroidal, anti-inflammatory drugs., and stringent government regulations coupled with the growing focus of major stakeholders in the healthcare industry to adopt to make antacids products more sustainable with fewer side effects and cost-effective. Major healthcare companies are investing heavily in their products due to rising social awareness regarding gastrointestinal cases, and other associated disorders, such as erosive esophagitis, Barrett esophagus, and esophageal cancer. According to World Gastroenterology Organization, the prevalence of GERD is increasing worldwide and ranges from nearly 2.5% to 6.6% in Eastern Asia and nearly 13.8% to 25.8% in North America. This rise in the prevalence of these disorders is contributing to market growth. Furthermore, many therapies are used for the treatment and the use of antacids significantly rises in such cases which is responsible for excessive use of antacids and also significantly contributes to the market for antacids. Therefore, the market for antacids is expected to witness significant growth during the forecast period.

GlaxoSmithKline plc., Pfizer Inc., Bayer AG, Dr. Reddy’s Laboratories Ltd., AstraZeneca PLC., Boehringer Ingelheim GmbH, Sun Pharmaceuticals Industries Ltd., Takeda Pharmaceutical Company Limited, Abbott Laboratories, Johnson & Johnson are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report

“Amongst Drug Class, proton pump inhibitors category accounted for the majority share in the market in 2020”

Based on drug class, the market is classified into proton pump inhibitors, H2 antagonists, acid neutralizers and others. Amongst types, the proton pump inhibitors category accounted for a significant share of the market. This is mainly due to its use in the treatment of gastroesophageal reflux disease (also known as GERD). This class is considered standard antacids and this type of drug reduce stomach acid production significantly and for a long time. This segment’s dominance is attributable to the presence of a large number of proton pump inhibitor antacids in the global market.

“Amongst Formulation, tablets are expected to witness highest CAGR during the forecast period”

Based on formulation, the market is categorized into tablets, capsules, suspension, drops, and others. Among these, the tablet is expected to witness the highest CAGR during the forecast period. This is mainly due to the strong prevalence of the presence of a variety of chewable tablets in the market with different flavors that help to improve patient adherence to the medication. Furthermore, supportive government initiatives to create awareness regarding the treatment options for gastric issues are expected to well for the adoption of innovative drugs. The continuous development of the new products and procedures is likely to strengthen the market of the segment during the forecast period.

“North America to witness significant growth during the forecast period”

North America is expected to show the highest CAGR growth in the antacids market. The major contributors to the growth of this market are US and Canada. The increase in technology development in emerging economies, as well as the expansion of the healthcare industry, has contributed to the growth of the North America market. North America has a higher adoption rate of medical treatment and antacid drugs. The enhanced awareness regarding the availability of various antacids has propelled the growth of the market in the region. Hence these require drugs in the region which drives the demand for antacids in the region. Furthermore, increasing geriatric population and new product launches, and various developmental strategies adopted by the regional market will drive market growth. Furthermore, according to the Centers for Disease Control and Prevention (CDC) 2018 statistics, the total number of adults diagnosed with ulcers in the United States was found to be 14.8 million. The number of populations with ulcers is proportional to the population suffering from GERD. Furthermore, the biopharmaceutical companies and diagnostics industry owing to the presence of well-established market players and frequent product launches in the region.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
  • The report presents a quick review of overall industry performance at one glance.
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
  • The study comprehensively covers the market across different segments.
  • Deep dive regional level analysis of the industry.

 

Customization Options:

Global antacids market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

1.1.Market Definitions
1.2.Main Objective 
1.3.Stakeholders
1.4.Limitation
2.1.Research Process of the Antacids Market
2.2.Research Methodology of the Antacids Market
2.3.Respondent Profile  

 

3MARKET SYNOPSIS

 

4EXECUTIVE SUMMARY

 

5GLOBAL ANTACIDS MARKET COVID-19 IMPACT

 

6GLOBAL ANTACIDS MARKET REVENUE (USD BN), 2020-2028F

 

7.1.Proton pump inhibitors
7.2.H2 antagonist
7.3.Acid neutralizers
7.4.Others 

 

8.1.Tablets
8.2.Capsules
8.3.Suspension
8.4.Drops
8.5.Others

 

9.1.Hospital Pharmacies
9.2.Retail Pharmacies
9.3.Online Pharmacies
9.4.Others 

 

10.1.North America 
 10.1.1.U.S. 
 10.1.2.Canada 
 10.1.3.Rest of North America 
10.2.Europe  
 10.2.1.Germany 
 10.2.2.UK 
 10.2.3.France 
 10.2.4.Italy 
 10.2.5.Spain 
 10.2.6.Rest of Europe
10.3.Asia-Pacific 
 10.3.1.China 
 10.3.2.Japan 
 10.3.3.India 
 10.3.4.Australia 
 10.3.5.Rest of Asia-Pacific
10.4.Rest of World 

 

11.1.Market Drivers
11.2.Market Challenges
11.3.Impact Analysis

 

12ANTACIDS MARKET OPPORTUNITIES

 

13ANTACIDS MARKET TRENDS

 

14POLICY & REGULATORY FRAMEWORK

 

15.1.Demand Side Analysis
15.2.Supply Side Analysis

 

16VALUE CHAIN ANALYSIS

 

17.1.Competitive Landscape
 17.1.1.Porter’s Five Forces Analysis 

 

18.1.GlaxoSmithKline plc. 
18.2.Pfizer Inc.  
18.3.Bayer AG   
18.4.Dr. Reddy’s Laboratories Ltd. 
18.5.AstraZeneca PLC.  
18.6.Boehringer Ingelheim GmbH 
18.7.Sun Pharmaceuticals Industries Ltd.
18.8.Takeda Pharmaceutical Company Limited
18.9.Abbott Laboratories  
18.10.Johnson & Johnson  

 

19DISCLAIMER

Research Methodology

Research Methodology for the Global Antacids Market Analysis (2022-2028)

Analyzing the historical market, estimation of the current market, and forecasting the future market of the global antacids market were the three major steps undertaken to create and analyze the adoption of antacids in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global antacids market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the antacids market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the antacids market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as a drug class, formulation, distribution channel, and region. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the antacids market. Further, we conducted factor analysis using dependent and independent variables such as drug class, formulation, distribution channel, and region of antacids. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the antacids market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global antacids market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of revenue (USD) and the adoption rate of antacids market across the major markets domestically
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the global antacids market in terms of solutions offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

 

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Antacids Market
Antacids Market

Market Engineering

Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global antacids market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of a drug class, formulation, distribution channel, and region in the global antacids market.

The main objective of the Global Antacids Market Study

The current & future market trends of the global antacids market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of the antacids market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include areas of a drug class, formulation, distribution channel, and region.
  • Define and analysis of the regulatory framework for the antacids market industry.
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
  • Analyze the current and forecast market size of the antacids market for the major region.
  • Major countries of regions studied in the report include North America, Europe, Asia Pacific, and Rest of the world.
  • Company profiles of the antacids market and the growth strategies adopted by the market players to sustain in the fast-growing market
  • Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?